Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
20 studies found for:    lebrikizumab
Show Display Options
Rank Status Study
1 Completed A Bioequivalence Study of Subcutaneous (SC) Lebrikizumab Administered by Needle and Syringe or by Prefilled Syringe With Needle Safety Device (PFS-NSD)
Condition: Healthy Volunteer
Intervention: Drug: Lebrikizumab
2 Terminated A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent Asthma
Condition: Asthma
Interventions: Drug: Lebrikizumab;   Drug: Placebo
3 Completed A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication
Condition: Asthma
Interventions: Drug: Lebrikizumab;   Drug: Placebo
4 Completed A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Condition: Asthma
Interventions: Drug: Lebrikizumab;   Drug: Placebo
5 Suspended A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home Setting
Condition: Asthma
Interventions: Drug: Lebrikizumab;   Device: Prefilled Syringes
6 Completed A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Condition: Chronic Obstructive Pulmonary Disease
Interventions: Drug: Lebrikizumab;   Drug: Placebo
7 Completed A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Lebrikizumab;   Drug: Topical corticosteroid (TCS) cream
8 Active, not recruiting A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled Asthma
Condition: Asthma
Interventions: Drug: Lebrikizumab;   Drug: Placebo;   Drug: Inhaled corticposteroids (ICS);   Drug: Second Asthma Controller Medication
9 Completed A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis
Condition: Atopic Dermatitis
Interventions: Drug: Lebrikizumab;   Drug: Placebo;   Drug: TCS Cream
10 Active, not recruiting A Study of Lebrikizumab in Participants With Idiopathic Pulmonary Fibrosis
Condition: Idiopathic Pulmonary Fibrosis
Interventions: Drug: Lebrikizumab;   Drug: Pirfenidone;   Drug: Placebo
11 Completed A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Condition: Asthma
Interventions: Drug: Lebrikizumab;   Drug: Placebo;   Drug: Standard of Care
12 Completed A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate Asthma
Condition: Asthma
Interventions: Drug: lebrikizumab;   Drug: montelukast [Singulair];   Other: placebo
13 Completed A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled Corticosteroids
Condition: Asthma
Interventions: Drug: lebrikizumab (MILR1444A);   Drug: placebo
14 Completed A Study of Lebrikizumab in Healthy Japanese and Caucasian Volunteers
Condition: Healthy Volunteer
Interventions: Drug: lebrikizumab;   Drug: placebo
15 Completed A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)
Condition: Asthma
Interventions: Drug: lebrikizumab;   Drug: placebo
16 Completed A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)
Condition: Asthma
Interventions: Drug: lebrikizumab;   Drug: placebo
17 Completed A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids
Condition: Asthma
Interventions: Drug: lebrikizumab (MILR1444A);   Drug: placebo
18 Completed A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic Asthma
Condition: Allergic Asthma
Interventions: Drug: lebrikizumab (MILR1444A);   Drug: placebo
19 Completed A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent Asthma
Condition: Asthma
Interventions: Drug: LABA;   Drug: corticosteroids;   Drug: prednisolone
20 Recruiting A Bronchoscopy Study to Assess the Effects of Inhaled Corticosteroids on Adult Healthy Volunteers
Condition: Healthy
Interventions: Drug: Fluticasone propionate;   Device: Accuhaler

Study has passed its completion date and status has not been verified in more than two years.